INTERCEPT PHARMACEUTICALS IN's ticker is ICPT and the CUSIP is 45845P108. A total of 177 filers reported holding INTERCEPT PHARMACEUTICALS IN in Q3 2015. The put-call ratio across all filers is 1.16 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2021 | $0 | – | 18 | 0.0% | 0.00% | – |
Q4 2020 | $0 | -100.0% | 18 | -96.1% | 0.00% | – |
Q3 2020 | $19,000 | -36.7% | 464 | -26.8% | 0.00% | – |
Q2 2020 | $30,000 | -38.8% | 634 | -19.7% | 0.00% | – |
Q1 2020 | $49,000 | -27.9% | 790 | +42.1% | 0.00% | – |
Q4 2019 | $68,000 | +88.9% | 556 | -1.4% | 0.00% | – |
Q3 2019 | $36,000 | -54.4% | 564 | -42.9% | 0.00% | – |
Q2 2019 | $79,000 | -24.8% | 987 | +5.2% | 0.00% | – |
Q1 2019 | $105,000 | +52.2% | 938 | +37.7% | 0.00% | – |
Q4 2018 | $69,000 | -22.5% | 681 | -2.0% | 0.00% | – |
Q3 2018 | $89,000 | +48.3% | 695 | -0.4% | 0.00% | – |
Q2 2018 | $60,000 | +5.3% | 698 | -25.5% | 0.00% | – |
Q1 2018 | $57,000 | -40.0% | 937 | -42.6% | 0.00% | – |
Q4 2017 | $95,000 | +25.0% | 1,633 | +24.6% | 0.00% | – |
Q3 2017 | $76,000 | -74.8% | 1,311 | -47.3% | 0.00% | – |
Q2 2017 | $302,000 | +31.9% | 2,490 | +23.3% | 0.00% | – |
Q1 2017 | $229,000 | +5.0% | 2,020 | +0.7% | 0.00% | – |
Q4 2016 | $218,000 | +581.2% | 2,006 | +903.0% | 0.00% | – |
Q3 2016 | $32,000 | -23.8% | 200 | -33.3% | 0.00% | – |
Q2 2016 | $42,000 | +250.0% | 300 | +200.0% | 0.00% | – |
Q1 2016 | $12,000 | +50.0% | 100 | +100.0% | 0.00% | – |
Q4 2015 | $8,000 | -50.0% | 50 | -50.0% | 0.00% | – |
Q3 2015 | $16,000 | -94.8% | 100 | -92.2% | 0.00% | – |
Q2 2015 | $308,000 | +214.3% | 1,280 | +265.7% | 0.00% | – |
Q1 2015 | $98,000 | +880.0% | 350 | +483.3% | 0.00% | – |
Q4 2014 | $10,000 | -65.5% | 60 | -51.2% | 0.00% | – |
Q3 2014 | $29,000 | -84.7% | 123 | -84.7% | 0.00% | – |
Q2 2014 | $189,000 | +8.6% | 802 | +52.2% | 0.00% | – |
Q1 2014 | $174,000 | – | 527 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Chicago Capital Management, LLC | 185,781 | $4,611,565 | 12.16% |
Samsara BioCapital, LLC | 640,688 | $11,878,356 | 3.64% |
ALPINE ASSOCIATES MANAGEMENT INC. | 2,203,295 | $40,849,089 | 2.14% |
Versor Investments LP | 378,480 | $7,017,019 | 1.42% |
Magnetar Financial LLC | 2,407,209 | $44,629,655 | 1.14% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,077,893 | $38,524,136 | 0.85% |
Fort Baker Capital Management LP | 430,600 | $7,983,324 | 0.74% |
EHP Funds Inc. | 84,210 | $1,561,253 | 0.73% |
Terrapin Asset Management, LLC | 30,000 | $556,200 | 0.63% |
AQR Arbitrage LLC | 734,970 | $13,626,344 | 0.61% |